HealthDay - WEDNESDAY, June 2 (HealthDay News) -- Two new tests promise to cut down on the number of biopsies now taken from men suspected of having prostate cancer, researchers report.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.